HCM Hutchison China Meditech ADRs

Hutchison China Meditech Ltd is a major drug manufacturing company. The company operates two platforms--an innovation platform and a commercial platform aimed at discovering and developing therapeutics in oncology and autoimmune diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol LN:HCM.

$29.23  -0.41 (-1.37%)
As of 04/14/2021 15:58:04 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  Cayman Islands
IPO date:  03/16/2016
Outstanding shares:  145,624,443
Average volume:  146,851
Market cap:   $4,314,852,246
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    44842L103
ISIN:        US44842L1035
Sedol:      BYXV9H7

---

Valuation   (See tab for details)

---

PE ratio:   -36.79
PB ratio:   8.87
PS ratio:   15.98
Return on equity:   -25.51%
Net income %:   -45.74%